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range 50–96.5 IU/L and, in only 4 out of 138 patients (2.9%),
levels above 200 IU/L (that is, ﬁve times above upper limit
of normal) were found (maximal value, 294). AST/ALT ratios
in these 4 patients were 0.61, 0.52, 0.78 and 0.55, similar
to the whole group of patients. Thus, we might suggest that
most of the patients were not showing a drug-induced liver
injury able to modify AST or ALT levels. The AST/ALT ratio
is a very important variable, strongly associated with the
presence of advanced ﬁbrosis in the univariate analysis (with
higher odds ratio than other variables) and therefore, is
included in both scoring systems, the NAFLD ﬁbrosis score
and the BARD score. Furthermore, in the BARD score, an
AST/ALT ratioP0.8 sums 2 points while the other two vari-
ables, presence of diabetes or body mass indexP28, sum only
1 point. However, the information on the list of medications
taken by the patients is also lacking in the two original stud-
ies [1,2].
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Letters to the EditorGender disparity and MELD in liver transplantation
To the Editor:
We read with great interest the paper by Myers et al. [1], recently
published in Journal of Hepatology, regarding the disparities
between males and females in the MELD-based allocation system
for liver transplantation. The authors found that women are dis-
advantaged under MELD, which may be attributable to the use of
serum creatinine (Cr) in MELD score equation [1]. This conﬁrms
our previously published work indicating a systematic bias
against women [2]. It is known that Cr is an inaccurate marker
of renal function, since its concentration is inﬂuenced by several
factors unrelated to renal function, such as total muscle mass,
leading to discrepancies in Cr concentration between individuals
with the same renal function [same glomerular ﬁltration rate
(GFR)] but of different age, race and sex [3].
We showed that Cr and GFR in females were lower than
males, and female gender might negatively inﬂuence the chances
of receiving a liver transplant with respect to men [2]. Correcting
Cr by equalising the GFR between men and women, resulted in an
increase in MELD score by up to 3 points in female LT candidates
[2]. Following this, Moylan et al. evaluated the UNOS database [4]
and showed that women were more likely to die on the waiting
list in the post-MELD era, compared to the pre-MELD one,
although women were listed with lower median MELD scores,
compared to men (14 vs. 15, p <0.001) [4]. In the UNOS database,
Myers et al. [1] found the same discrepancies, as we did [2]:
women, compared with men, had lower Cr (0.9 vs. 1.0 mg/dl,
and MELD 16.5 vs. 17.2, both p <0.001), but worse renal function
(estimated GFR: 72 vs. 83 mL/min, p <0.001); however they were
less likely to undergo liver transplantation (LT), and had greater
3-month mortality. Interestingly, Myers et al. [1] also found that
patients with cirrhosis with a black ethnicity had a lower mortal-
ity, compared to white ethnicity. We believe that this likely to be
related to Cr: black patients as a group have a higher Cr (more
muscle mass), compared to white, for the same renal function,
and, thus, MELD score may overestimate the severity of their liver
disease. Indeed, MDRD calculations of GFR commonly have a cor-
rection factor for black race.
However Myers et al. did not ﬁnd that using a calculated GFR
(eGFR based on MDRD formula) helped to discriminate a different
prognosis for men vs. women [1]. However, the evaluation with
eGFR (MDRD formula), and not with ‘‘true’’ GFR using a gold stan-
dard method, could explain the discrepant results regarding the
comparison presented of MELD-(Sodium)-eGFR and MELD-
(Sodium) as the authors themselves suggested [1]. In contrast,
Lim et al. [5] (using 125I-iothalamate for true GFR) found that
‘‘true’’ GFR was superior to Cr in assessing mortality risk on the
waiting list and its incorporation in the MELD score (in the place
of Cr), led to a signiﬁcant improvement of discriminative ability
of MELD. Unfortunately, Lim et al. [5] did not evaluate the prog-
nostic impact of MELD-Cr and MELD-GFR scores in men and
women candidates separately.
Secondly, it is possible that the higher mortality of women
placed on waiting lists for liver transplantation [1,4], compared
to men, could be related to the presence of signiﬁcant differences
for matching of donor organ size to either recipient men or
women, and thus, longer waiting times for women compared to
men. Unfortunately, Myers et al. [1] did not evaluate this param-
eter. However, Lai et al. [6] recently suggested that height con-
tributes to the gender disparity, possibly reﬂecting differences
in transplantation rates for shorter individuals. The authors500 Journal of Hepatology 2011 vol. 55 j 497–501
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showed that short stature is related with higher risk of death for
both men and women. Since women have shorter stature, com-
pared to men, this could explain the higher waiting list mortality
of women. However, data regarding the waiting time between
men and women, or between different heights of candidates were
not provided, and height cannot totally explain this disparity.
Thus, as the authors recognized [6], further investigation is
needed to clarify the issue of gender disparity and organ alloca-
tion in liver transplantation.
Nevertheless, it seems that female gender predicts lower
transplantation rates, independently of height. A further recent
study [7] again showed that women had lower transplantation
rates and a substantially higher mortality risk on the LT waiting
list, particularly when eGFR was between 15 and 30 ml/min,
due to underestimation of renal dysfunction in women, when
Cr was used for MELD score calculation.
As we stated [2], we believe that a correction factor for gender
and ethnicity should be introduced for equitable allocation in
liver transplantation particularly if a MELD based system is used.
As ‘‘true’’ GFR is difﬁcult to perform routinely, and new serum
markers, such as cystatin C and its mathematical formulae, seem
to offer no signiﬁcant advantage, compared to Cr and the MDRD
formula, in patients with cirrhosis [8], a different parameter is
needed. Thus, a simple increase of points should be instituted
for women awaiting LT when MELD is used, or indeed in other
formulae that use Cr, as unequal access to transplantation
between men and women has now been shown by several groups
[1,4,6,7] following our ﬁrst report [2].
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